Trials of the world's first tooth regrowth medicine are set to commence in September at Kyoto University Hospital. The researchers behind the medicine hope to start selling it in 2030. There have been no major side effects confirmed in animal studies to date. The medicine deactivates a protein called USAG-1, which inhibits the growth of teeth. The medicine is currently targeted at patients congenitally lacking a full set of teeth.
Monday, May 6, 2024